"I think that there are some companies that do a great job [with obesity treatment] and others where they are simply dispensing the medication, and there's no follow-up or there's no ability to monitor someone's conditions," she said
J Clin Anesth 17(3):221-224
Profumo E, Di Franco M, Buttari B, Masella R, Filesi C, Tosti ME, Scrivo R, Scarno A, Spadaro A, Saso L, Rigan R
The results suggested that the incidence of AEs was markedly lower with canagliflozin (RR = 0.97, 95% CrI: 0.94, 0.99) and empagliflozin (RR = 0.99, 95% CrI: 0.97, 1.00) than placebo ( Figure 5b )
Lab tests also showed that T4 helped skin cells move 2 to 3 times faster than normal, even when used in tiny amounts